Global demand for rapid diagnostics continues to accelerate as the U.S. market is forecast to reach USD 7.10 Billion by 2035 and Europe USD 6.36 Billion, supported by expanding home testing, clinical ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...